Shu-en focuses her practice on M&A, venture capital and private equity transactions. She has experience representing emerging companies, as well as private equity and VC investors, in the US and Asia. In 2022, Asian Legal Business named Shu-en on its inaugural Singapore Rising Stars list.
Cooley Advises Investor Syndicate on $2.25 Billion Acquisition of HistoSonics
August 7, 2025
Cooley advised a syndicate of globally recognized private and public investors in connection with the management-led majority stake acquisition of HistoSonics, the developer of the Edison Histotripsy System and novel histotripsy therapy platform, valuing the company at approximately $2.25 billion.
Cooley advised Zepto, India’s fast-growing quick commerce company, on its $665 million Series F financing, more than doubling its valuation to $3.6 billion in less than a year.
ChrysCapital Closes Largest Continuation Fund in India, Maintaining Stake in NSE
May 2, 2024
Cooley advised ChrysCapital, a top India-focused private equity firm, on the close of its oversubscribed $700 million continuation fund and general partner-led secondary transaction to purchase and sell its stake in the National Stock Exchange of India (NSE) with two of the world’s leading secondary fund investors. The landmark transaction is the largest of its kind in India and ranks among the largest in the Asia-Pacific region.
Affable Technologies Sells affable.ai to Bazaarvoice
October 10, 2023
Cooley advised Affable Technologies, an artificial intelligence-based influencer marketing platform, on the sale of its affable.ai platform to Bazaarvoice, a leading provider of full-funnel authentic user-generated content solutions.
